Ambiguous Genetic Test Results Can Be Unsettling. Worse, They Can Lead to Needless Surgeries
Basser Executive Director Susan Domchek, MD, was quoted in a story on the ambiguity of certain genetic tests and how “variants of unknown significance” (VUS) can guide cancer treatments, despite a lack of evidence to support those decisions.
BRCA Rules Leave Patients Behind
New guidelines from USPSTF on BRCA genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk, according to critics of the update, including Basser’s Susan Domchek, MD.
Family Matters: The Link Between Family History & BCRA Mutations
Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD.
Nina Garcia Honored At Basser Center Gala For Cancer Research
Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINX & BRCA, an initiative to raise awareness of hereditary cancer in the Latinx community.
Abramson Cancer Center Experts Take Part in NBC10/AACR Telethon
Experts from Penn Medicine's Abramson Cancer Center, including Basser Genetic Counselor Dana Farengo Clark, MS, LCGC, answered questions about cancer from NBC10 Philadelphia viewers as part of a telethon in partnership with the American Association for Cancer Research.
A Brighter Outlook for Metastatic Breast Cancer
Payal D. Shah, MD, an assistant professor of Hematology-Oncology at Penn Medicine and a member of the Basser Center, spoke about new treatments that are letting people live longer and improving quality of life for some patients with metastatic breast cancer.
Event in Manhattan raises over $8.5 million for research on BRCA-related cancers
The Basser Center for BRCA held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers.
Home Genetic Testing Kits Sound like a Great Idea — Until They Aren’t
Throughout October, Penn Medicine physicians, patients, and advocates are contributing to breast cancer awareness month with a series of op-eds for the Philadelphia Inquirer. In this week’s piece, Dana Farengo Clark, MS, LCGC, a senior genetics counselor at the Basser Center, talked about the risks and drawbacks of at-home genetic testing.
Meet the 2019 Breast Health Champions
Basser Executive Director Susan Domchek, MD, has been featured as one of Philadelphia Magazine's 2019 Breast Health Champions. In this interview with her, she discusses the role of medical oncologists, hereditary cancer, and what both men and women should know about their potential risk for breast cancer.
Expert Discusses the Selection of Individuals for Germline Testing Based on Breast Cancer Risk
Susan Domchek, MD, Executive Director of the Basser Center, discusses current guidelines and evolving best practices about when to order genetic testing for patients.
What’s Your Family History? with Susan M. Domchek, MD
Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.
Dr. Domchek on Results of the MEDIOLA Trial in BRCA-Mutated Metastatic Breast Cancer
Basser Executive Director, Susan Domchek, MD, discusses the results of the MEDIOLA trial in germline BRCA-mutated metastatic breast cancer.
Wellness Wednesday: Breast Cancer in Men
WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center for BRCA, about breast cancer in men, genetic risks, and what patients should know.
Mathew Knowles Reveals He is Battling Breast Cancer
Matthew Knowles shares his story with Good Morning America and discusses male breast cancer and BRCA. Basser Executive Director Susan Domchek, MD, was interviewed for the piece and shares that "men with BRCA2 mutations have a particular increased risk of male breast cancer" and other cancers.
Beyoncé’s Dad Has a Mutation More African-Americans Should Be Tested For
Basser Young Leadership Council co-chair Erika Stallings writes for The New York Times about the importance of genetic testing for African Americans.
Breast Cancer, Genetics and the Milestone that Keeps Bringing Hope Closer
Basser Executive Director Susan Domchek, MD, marks 25 years since BRCA1 was first cloned. She explores the advances in the field since that milestone and looks to the future for areas of growth.
25 Years of BRCA: How a Cancer Milestone Has Changed the Field
2019 represents a specific milestone in the fight. It’s been 25 years since the BRCA1 gene was first cloned — a discovery that accelerated cancer research and opened a new path for exploration in cancer prevention and treatment.
Breast Cancer is a Family Legacy for This Young Latina
For Hispanic Heritage Month and Breast Cancer Awareness Month, Alejandra Campoverdi writes for the Philadelphia Inquirer about her personal experience with hereditary cancer.
Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize
Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.